LYON, France, January 29, 2020 – EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that the University of Miami Sylvester Comprehensive ...

Men hoping to avoid some of the dreaded side effects of prostate cancer treatment are shelling out tens of thousands of dollars for a new procedure whose long-term effects are unknown, even though ...

FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical AUSTIN, Texas, June 16, 2026 (GLOBE NEWSWIRE) -- FocalTherics (Nasdaq: ...

Men hoping to avoid some side effects of prostate cancer treatment are shelling out tens of thousands of dollars for a procedure whose long-term effects are unknown and insurers, including Medicare, ...

The first ultrasound system for the ablation of prostate tissue in the United States has just been approved by the Food and Drug Administration (FDA). The Sonablate 450, developed by SonaCare Medical, ...

TOKYO, Oct. 16, 2024 /PRNewswire/ -- SONIRE Therapeutics Inc. (hereinafter referred to as "SONIRE"), based in Tokyo, Japan, announces that its self-developed next-generation HIFU (High-Intensity ...

LYON, France, September 28, 2021-- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that University of Washington Medicine has acquired ...

A urologist who was once called "one of the most dangerous doctors" in Florida and who specialized in the treatment of prostate cancer with high-intensity focused ultrasound (HIFU) has been arrested ...

Toosonix A/S has launched two trials as it moves to gather data enabling its high-intensity focused ultrasound (HIFU) device to get approval for use in clinical dermatology indications. The company ...

Co announces EDAP TMS and China Medical Technologies (CMED) today announced an exclusive agreement in which EDAP will distribute China Medical's HIFU tumor therapy systems in the European Union and ...